These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
159 related articles for article (PubMed ID: 7542483)
1. [The cost-benefit of interferon therapy in chronic viral liver diseases]. Ascione A; De Luca M Minerva Gastroenterol Dietol; 1995 Mar; 41(1):123-5. PubMed ID: 7542483 [No Abstract] [Full Text] [Related]
2. Economic modeling of treatment in chronic hepatitis B and chronic hepatitis C: promises and limitations. Koff RS; Seeff LB Hepatology; 1995 Dec; 22(6):1880-2. PubMed ID: 7490001 [No Abstract] [Full Text] [Related]
3. Interferon and other therapies for hepatitis B and hepatitis C infections. Rothstein KD; Munoz SJ Clin Lab Med; 1996 Jun; 16(2):465-91. PubMed ID: 8792083 [TBL] [Abstract][Full Text] [Related]
12. Interferons in the management of viral hepatitis. Zein NN Cytokines Cell Mol Ther; 1998 Dec; 4(4):229-41. PubMed ID: 10068057 [TBL] [Abstract][Full Text] [Related]
13. [Interferon and the liver]. Poitrine A; Chousterman S; Chousterman M Gastroenterol Clin Biol; 1986; 10(8-9):589-603. PubMed ID: 2430851 [No Abstract] [Full Text] [Related]
15. [The treatment of viral hepatitis]. Dhumeaux D Servir; 1991; 39(6):304-5. PubMed ID: 1723221 [No Abstract] [Full Text] [Related]
16. [Predictive factors of response to interferon in chronic hepatitis]. Forns X; Ampurdanés S Gastroenterol Hepatol; 1995; 18(7):388-95. PubMed ID: 7553278 [No Abstract] [Full Text] [Related]
17. [Treatment of chronic viral hepatitis B and C]. Stránský J Vnitr Lek; 1997 Jan; 43(1):41-4. PubMed ID: 9221566 [No Abstract] [Full Text] [Related]
18. Cost-effective options for the prevention and management of gastrointestinal and liver disease in the Asia-Pacific region. Roberts-Thomson IC; Lung T J Gastroenterol Hepatol; 2018 Jan; 33(1):121-127. PubMed ID: 28833619 [TBL] [Abstract][Full Text] [Related]
19. [Treatment with interferon in chronic hepatitis. General Subdirectorate of Services and Evaluation of Health Technologies, General Directorate of Assurance and Health Planning, Ministry of Health and Consumption]. Med Clin (Barc); 1994 Oct; 103(13):498-504. PubMed ID: 7527884 [No Abstract] [Full Text] [Related]
20. [Report on interferon treatment in chronic hepatitis. Office of the General Deputy Director of Benefits and Evaluation of Health Technologies. Office of the General Director of Insurance and Health Planning]. Gastroenterol Hepatol; 1995 Jan; 18(1):33-41. PubMed ID: 7542554 [No Abstract] [Full Text] [Related] [Next] [New Search]